Holen Sie sich die Stockscreener-App
135.60
0.61%
-0.24
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$135.84
Offen:
$134.95
24-Stunden-Volumen:
412.28K
Relative Volume:
0.04
Marktkapitalisierung:
$334.43B
Einnahmen:
$65.51B
Nettoeinkommen (Verlust:
$8.93B
KGV:
38.16
EPS:
3.5532
Netto-Cashflow:
$14.12B
1W Leistung:
+3.13%
1M Leistung:
+5.89%
6M Leistung:
+11.06%
1J Leistung:
+60.33%
1-Tages-Spanne:
$134.55
$136.07
1-Wochen-Bereich:
$128.91
$136.07
52-Wochen-Spanne:
$77.58
$136.07
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
135.55 | 335.14B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,175.20 | 1.05T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
260.18 | 627.42B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
249.35 | 440.83B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
151.40 | 286.78B | 54.66B | 13.58B | 16.05B | 7.0171 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-20 | Eingeleitet | Barclays | Overweight |
| 2026-02-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
ABN Amro Investment Solutions Has $39.71 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck stock trades close to its 12-month high as Q2 2026 growth and Keytruda momentum support the ou - ad-hoc-news.de
Mirae Asset Global Investments Co. Ltd. Buys 245,665 Shares of Merck & Co., Inc. $MRK - MarketBeat
Exchange Traded Concepts LLC Has $14.57 Million Holdings in Merck & Co., Inc. $MRK - marketbeat.com
QV Investors Inc. Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
LS Investment Advisors LLC Has $2.88 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Novem Group Has $7.20 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Envestnet Portfolio Solutions Inc. Acquires 23,240 Shares of Merck & Co., Inc. $MRK - MarketBeat
CV Advisors LLC Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc.: Target Price Consensus and Analysts Recommendations | 0QAH | US58933Y1055 - marketscreener.com
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Jennifer Zachary At Merck & Co Capitalizes: Options Exercised, Resulting In $1.33M - Benzinga
Merck stock trades near 52-week highs as Keytruda drives 2026 growth - ad-hoc-news.de
Thomasville National Bank Invests $5.49 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck stock climbs after a $16.61 billion quarter - AD HOC NEWS
Insider Selling: Merck & Co., Inc. (NYSE:MRK) EVP Sells 10,000 Shares of Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) EVP Jennifer Zachary Sells 80,315 Shares - MarketBeat
Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine - Yahoo Finance
QUICK SPARK: Dell, JPMorgan, Merck All Mark New All-Time Highs - Benzinga
Merck & Co. (MRK) EVP Chirfi Guindo sells 10,000 common shares - Stock Titan
Merck & Co., Inc. (NYSE:MRK) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Merck & Co. Insider Sold Shares Worth $10,718,495, According to a Recent SEC Filing - Moomoo
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
What Is Keeping Merck & Co (NYSE:MRK) In The Healthcare Spotlight? - Kalkine Media
Merck (MRK) EVP Jennifer Zachary exercises options and sells 80,315 shares - Stock Titan
Merck stock holds near a 52-week high after Q2 beat - AD HOC NEWS
Merck & Co., Inc. $MRK Shares Bought by Moody Lynn Lieberson & Walker LLC - MarketBeat
Mission Wealth Management LP Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Prevail Innovative Wealth Advisors LLC Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat
Resilient Merck stock holds near $133 after Daiwa upgrade and mixed Q2 2026 earnings - AD HOC NEWS
Merck & Co., Inc. (NYSE:MRK) EVP Richard Deluca Sells 20,784 Shares of Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) EVP Richard Deluca Sells 11,699 Shares of Stock - MarketBeat
Insider Selling: Merck & Co., Inc. (NYSE:MRK) EVP Sells 12,837 Shares of Stock - MarketBeat
Merck & Co. Insider Sold Shares Worth $5,942,369, According to a Recent SEC Filing - marketscreener.com
Merck & Co. (MRK) EVP Richard DeLuca sells 45,320 shares over three days - Stock Titan
Merck & Co., Inc. (NYSE:MRK) Upgraded at Daiwa Securities Group - MarketBeat
Daiwa Upgrades Merck & Co. to Outperform From Neutral, Adjusts PT to $143 From $120 - marketscreener.com
Argus Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
Argus Adjusts Price Target on Merck & Co. to $145 From $130, Keeps Buy Rating - marketscreener.com
Merck & Company, Inc. (MRK) Stock Forecasts - Yahoo Finance
Handelsbanken Fonder AB Raises Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Holdings Lifted by Generali Investments Management Co LLC - MarketBeat
KMG Fiduciary Partners LLC Sells 26,888 Shares of Merck & Co., Inc. $MRK - MarketBeat
Sapient Capital LLC Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Carolina Wealth Advisors LLC Sells 15,954 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bay Colony Advisory Group Inc d b a Bay Colony Advisors Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Trump Limits Childhood Vaccines As Bill Cassidy Warns Of RisksMerck & Co (NYSE:MRK), Sanofi (NASDAQ:SN - Benzinga
Merck & Co Inc (MRK) EVP & President of Merck Animal Health Rich - GuruFocus
Merck & Co., Inc. (NYSE:MRK) EVP Sells 6,050 Shares - MarketBeat
Merck (MRK) animal health chief DeLuca sells 6,050 shares - Stock Titan
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):